LifeMD (LFMD) Competitors $6.20 +0.09 (+1.47%) As of 02:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFMD vs. AVAH, AHCO, TDOC, GRAL, PNTG, CDNA, FLGT, FTRE, CSTL, and OMDAShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Aveanna Healthcare (AVAH), AdaptHealth (AHCO), Teladoc Health (TDOC), GRAIL (GRAL), The Pennant Group (PNTG), CareDx (CDNA), Fulgent Genetics (FLGT), Fortrea (FTRE), Castle Biosciences (CSTL), and Omada Health (OMDA). These companies are all part of the "healthcare" industry. LifeMD vs. Its Competitors Aveanna Healthcare AdaptHealth Teladoc Health GRAIL The Pennant Group CareDx Fulgent Genetics Fortrea Castle Biosciences Omada Health Aveanna Healthcare (NASDAQ:AVAH) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk. Is AVAH or LFMD more profitable? Aveanna Healthcare has a net margin of 0.85% compared to LifeMD's net margin of -2.41%. LifeMD's return on equity of 0.00% beat Aveanna Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Aveanna Healthcare0.85% -54.56% 3.17% LifeMD -2.41%N/A -8.11% Do insiders and institutionals have more ownership in AVAH or LFMD? 88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 7.8% of Aveanna Healthcare shares are held by insiders. Comparatively, 18.4% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media prefer AVAH or LFMD? In the previous week, Aveanna Healthcare had 3 more articles in the media than LifeMD. MarketBeat recorded 10 mentions for Aveanna Healthcare and 7 mentions for LifeMD. Aveanna Healthcare's average media sentiment score of 0.65 beat LifeMD's score of -0.17 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive LifeMD 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, AVAH or LFMD? Aveanna Healthcare has a beta of 1.95, meaning that its stock price is 95% more volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.72, meaning that its stock price is 72% more volatile than the S&P 500. Which has higher earnings and valuation, AVAH or LFMD? Aveanna Healthcare has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAveanna Healthcare$2.18B0.70-$10.93M$0.0891.06LifeMD$245.56M1.20-$18.88M-$0.21-29.52 Do analysts rate AVAH or LFMD? Aveanna Healthcare presently has a consensus price target of $7.50, indicating a potential upside of 2.95%. LifeMD has a consensus price target of $12.86, indicating a potential upside of 107.37%. Given LifeMD's stronger consensus rating and higher possible upside, analysts clearly believe LifeMD is more favorable than Aveanna Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aveanna Healthcare 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60LifeMD 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryAveanna Healthcare beats LifeMD on 10 of the 17 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMD vs. The Competition Export to ExcelMetricLifeMDMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$294.22M$7.76B$5.75B$9.58BDividend YieldN/A2.75%4.54%4.09%P/E Ratio-29.5573.9530.3824.94Price / Sales1.2027.53415.42178.09Price / CashN/A23.8337.3459.16Price / Book620.0016.618.936.27Net Income-$18.88M$243.33M$3.26B$265.47M7 Day Performance-10.01%-0.24%-0.31%-2.09%1 Month Performance-41.23%2.18%3.69%0.30%1 Year Performance19.23%12.82%28.52%20.65% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDLifeMD2.3928 of 5 stars$6.20+1.5%$12.86+107.4%+14.8%$294.22M$245.56M-29.55230AVAHAveanna Healthcare2.2562 of 5 stars$6.83+11.2%$6.10-10.7%+39.5%$1.28B$2.02B85.3833,500News CoverageAnalyst UpgradeAHCOAdaptHealth3.8959 of 5 stars$9.33+1.5%$13.40+43.6%-11.1%$1.24B$3.26B17.2810,500Positive NewsTDOCTeladoc Health3.254 of 5 stars$6.79-2.5%$9.76+43.9%+2.2%$1.23B$2.57B-5.705,500GRALGRAIL1.0727 of 5 stars$32.69-0.4%$31.50-3.6%+87.1%$1.18B$125.60M-0.541,360PNTGThe Pennant Group3.6586 of 5 stars$26.15+0.6%$33.80+29.3%-21.2%$898.61M$695.24M33.537,000CDNACareDx4.2814 of 5 stars$11.77-1.7%$27.67+135.1%-66.0%$637.13M$333.79M11.54740Gap DownFLGTFulgent Genetics3.6658 of 5 stars$20.61+1.2%$25.33+22.9%-9.4%$623.20M$283.47M-12.421,313FTREFortrea3.9607 of 5 stars$6.39-2.9%$14.00+119.1%-64.8%$597.46M$2.70B-0.5615,500Positive NewsCSTLCastle Biosciences2.4166 of 5 stars$19.16-1.0%$37.00+93.1%-28.8%$561.60M$332.07M-54.74540OMDAOmada HealthN/A$19.06+0.2%$24.57+28.9%N/A$489.77MN/A0.00849 Related Companies and Tools Related Companies Aveanna Healthcare Competitors AdaptHealth Competitors Teladoc Health Competitors GRAIL Competitors The Pennant Group Competitors CareDx Competitors Fulgent Genetics Competitors Fortrea Competitors Castle Biosciences Competitors Omada Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMD) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access